Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Stay the course!
Thanks so much for your advice eskay1954, I’ll just sell all my shares tomorrow then, on the random thoughts of some obscure poster who seldom, if ever, contributes to this board?
Well stated basparks79...you echo my thoughts and those of many other long term shareholders.
Agreed basparks79, and I was a buyer today.
Congratulations Sir!
Great stuff Peter!
Well done sir, hats off! You should be involved with Investor’s Relations! See if Anavex has an opening.
Yes, not a big fan of Red or Orange these days. Green would be great though!
Missling is doing an excellent job guiding this baby biotech over and through the regulatory and financial hurdles and changing CEO’s now would guarantee a drop in share price. Just dumb to think otherwise.
Well stated tredenwater2! I could not agree more.
Well stated basparks79!
Oh yes, me too! Where can I sign up to always see the glass half empty? I want that investment newsletter!
Glad that I don’t take Investment advice from you.
Well said Investor2014! I never, ever expect to read anything positive when I see an OFP post on this board. The position taken is always, ALWAYS without exception, negative and leaves no doubt about where his allegiance lies.
If you over promote at this stage of the drug’s development, you also invite the dregs of the legal profession to file frivolous law suits. I think this is why Anavex is being careful about any claims of efficacy and curative or preventative powers.
I hope that you are correct here and that we truly do have Gottlieb as an advocate who understands what Anavex has to offer in the Alzheimer’s space and beyond. For me, he’s the singular Presidential Appointee, that warrants the position.
You speak the inconvenient truth basparks79, and as a fellow long term shareholder, I absolutely agree with your assessment of the current state of Anavex Life Sciences. Good things come to those who wait.
I’m very much enjoying the sarcasm employed here!!!
I think so too, unless we get some partnering news or earth shattering data.
I agree, and suspected the same due to our “game changing” science and the ramifications that it has for the bottom line of existing Big Pharma.
Great post and read Biostockclub. I liked your analysis!
Love it basparks79!
Lots of Alzheimer’s patients and caregivers praying for a miracle is more like it.
Sure thing BIOChecker4...but, but what about the ongoing MTA (Material Transfer Agreement) with Biogen for Anavex’s A2-73 as it relates to the MS (Multiple Sclerosis) indication?Explain to us all why this has not been terminated then??? Instead, there has been a cloak of secrecy surrounding this Agreement and I expect that we will hear more about this in the future.
The sky is falling, the sky is falling! You’re “take” on this stock appears to be from someone who might be betting against it (Short position) so the “facts” as you have spun them here, have a negative bias and a predictably dismal outcome. Your credibility is wanting and you do not accurately depict the opportunity and viability that is Anavex Life Sciences. I am a long term shareholder and will clearly and fairly state my relationship to this stock.
Well said basparks79! We know what we own and ignore all the detractors until something substantive says otherwise. Right now, on this day and moving forward, the science, data and promise that Anavex’s drug platform holds, makes this investment a very good bet. In Missling I trust to guide us to the promised land.
That was my thought too. This Doc here is a bit fast and loose with his conclusions and “insight”. I thought Erv represented himself well in the taped interview and will go with his personal perspective that is overall well being has improved once being administered with Anavex’s A2-73.
Agreed, why would anybody who’s so negative on this company hang around and continue to post here? I’d be inclined to ignore and accumulate according to your means. The science has not changed and there have actually been few negatives other than delayed trials to wait on. I’m a patient man, and go by the maxim that good things come to those who wait.
I agree!
I’m about to, so you’re actually wrong about that.
Agreed basparks79, we are in it to win it! I always wonder what motivates those who are constant detractors on this ihub site and it gives me confidence that I know what I own. I assume that they know what I own too and are being paid to cast doubt among the faithful, freeing up shares and dissuading others from investing.
Apparently it’s time to back up the Brink’s truck and buy more shares at these discounted prices.
My target price looks like 1,250 as well Puffdaddy. Anavex now on multiple CNS disease fronts!
I beg to differ, you discount all the hard work and savvy decisions CEO Missling has made to position this company for success. He wisely focuses on the things he can control and ignores the noise from internet message boards. I believe that he has the support of most long term investors and knows that the share price valuation will take care of itself in time.
Thanks Fireman for clarifying this desperate attempt at revisionist history regarding Anavex’s Trial designs as it relates to Rett’s Syndrome, Alzheimer’s, and Parkinson’s disease.
Perhaps a hostile takeover in the works as shares are scooped up at bargain prices? Pure conjecture on my part.
Adjusting to a changing FDA.
Thanks basparks79, I couldn’t agree more with your assessment of Mr. Plato.
Well stated Bourbon!
That would be lovely but my over riding concern is that Anavex has all their proverbial “ducks in a row” as they announce that step. I’m very invested in this company and am looking for a big return...make no mistake.